Logo image of PIII

P3 HEALTH PARTNERS INC (PIII) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:PIII - US7444132044 - Common Stock

5.24 USD
-0.01 (-0.22%)
Last: 12/5/2025, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
PIII revenue by date.PIII revenue by date.
1.05B
64.65%
1.266B
20.66%
1.5B
18.48%
1.459B
-2.76%
1.638B
12.27%
1.651B
0.79%
EBITDA
YoY % growth
PIII ebitda by date.PIII ebitda by date.
-158.61M
11.48%
-81.255M
48.77%
-226.542M
-178.80%
-100.178M
55.78%
-33.425M
66.63%
-12.658M
62.13%
EBIT
YoY % growth
PIII ebit by date.PIII ebit by date.
-245.9M
-30.87%
-167.93M
31.71%
-312.6M
-86.15%
-159.779M
48.89%
-111.911M
29.96%
-95.286M
14.86%
Operating Margin
PIII operating margin by date.PIII operating margin by date.
-23.43%-13.26%-20.83%-10.95%-6.83%-5.77%
EPS
YoY % growth
PIII eps by date.PIII eps by date.
-149.50
-236.94%
-32.50
78.26%
-46.50
-43.08%
-30.30
34.84%
-12.52
58.68%
-0.27
97.88%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-7.70
60.53%
-3.73
40.64%
-2.77
55.47%
-2.59
73.26%
-0.03
99.60%
Revenue
Q2Q % growth
363.43M
-1.96%
426.63M
14.31%
409.39M
15.07%
394.06M
14.14%
399.89M
10.03%
EBITDA
Q2Q % growth
-19.492M
56.09%
-13.367M
21.54%
-5.906M
-173.72%
-4.197M
-122.16%
2.3M
111.80%
EBIT
Q2Q % growth
-41.033M
68.54%
-29.691M
22.05%
-22.17M
35.03%
-36.992M
16.35%
-19.084M
53.49%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-9.67
33.31%
-6.16-3.51-57.05%
Q2 2025
Q2Q % growth
-6.23
-38.44%
-4.83-1.40-28.86%
Q1 2025
Q2Q % growth
-6.28
21.50%
-9.092.8130.94%
Q4 2024
Q2Q % growth
-19.50
-77.27%
-4.18-15.32-366.28%
Q3 2024
Q2Q % growth
-14.50
-141.67%
-1.91-12.59-658.17%
Q2 2024
Q2Q % growth
-4.50 -2.55-1.95-76.47%
Q1 2024
Q2Q % growth
-8.00
27.27%
-5.44-2.56-47.05%
Q4 2023
Q2Q % growth
-11.00
90.27%
-5.61-5.39-96.08%
Q3 2023
Q2Q % growth
-6.00
55.56%
-11.225.2246.52%
Q2 2023
Q2Q % growth
-4.50
57.14%
-6.632.1332.13%
Q1 2023
Q2Q % growth
-11.00
12.00%
-34.4323.4268.05%
Q4 2022
Q2Q % growth
-113.00
-841.67%
-46.41-66.59-143.48%
Q3 2022
Q2Q % growth
-13.50 -23.6310.1342.87%
Q2 2022
Q2Q % growth
-10.50 -8.16-2.34-28.68%
Q1 2022
Q2Q % growth
-12.50 -6.29-6.21-98.73%
Q4 2021
Q2Q % growth
-12.00 -12.410.413.30%
PIII Yearly EPS VS EstimatesPIII Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -50 -100 -150 -200 -250
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
345.253M
-4.66%
353.57M-8.317M-2.35%
Q2 2025
Q2Q % growth
355.788M
-6.16%
365.39M-9.602M-2.63%
Q1 2025
Q2Q % growth
373.225M
-3.93%
365.51M7.715M2.11%
Q4 2024
Q2Q % growth
370.686M
6.87%
385.62M-14.934M-3.87%
Q3 2024
Q2Q % growth
362.124M
25.58%
371.74M-9.616M-2.59%
Q2 2024
Q2Q % growth
379.157M
15.22%
391.14M-11.983M-3.06%
Q1 2024
Q2Q % growth
388.488M
28.61%
359.51M28.978M8.06%
Q4 2023
Q2Q % growth
346.861M
34.34%
309.03M37.831M12.24%
Q3 2023
Q2Q % growth
288.351M
16.13%
299.28M-10.929M-3.65%
Q2 2023
Q2Q % growth
329.086M
22.11%
310.01M19.076M6.15%
Q1 2023
Q2Q % growth
302.077M
10.45%
288.56M13.517M4.68%
Q4 2022
Q2Q % growth
258.2M
45.14%
258.01M190K0.07%
Q3 2022
Q2Q % growth
248.3M
58.66%
263.21M-14.91M-5.66%
Q2 2022
Q2Q % growth
269.5M
-11.05%
237.46M32.04M13.49%
Q1 2022
Q2Q % growth
273.5M 204.07M69.43M34.02%
Q4 2021
Q2Q % growth
177.9M
42.43%
182.42M-4.52M-2.48%
Q3 2021
Q2Q % growth
156.5M
21.51%
%
Q2 2021
Q2Q % growth
302.983M
30.70%
%
PIII Yearly Revenue VS EstimatesPIII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-34.04% -34.04% -30.11% -74.17%
Revenue1.6% 1.6% 0.27% 0%